FDA Endorses AstraZeneca’s Imfinzi for Early-Stage Lung Cancer Treatment Business 16 August 2024 AstraZeneca’s innovative drug, Imfinzi, now has the US FDA’s approval for treating early-stage lung cancer. This marks a significant milestone…
